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Alopecia areata (AA) is an autoimmune hair loss disease, that can be transferred between C3H/HeJ mice by skin
grafting. We explored whether AA susceptibility is inﬂuenced by the availability of interleukin (IL)-2, a cytokine with
leukocyte activating and regulatory properties. Mice heterozygous for a targeted deletion of IL-2 from the histo-
compatible C3.129P2(B6)-Il2tm1Hor substrain, that produce reduced levels of IL-2, were examined for AA develop-
ment after grafting skin from AA-affected C3H/HeJ mice. After grafting, nine of 19 (47%) heterozygous IL-2þ /
versus 16 of 18 (88%) IL-2þ /þ wild-type littermates developed AA. Although dense follicular leukocyte inﬁltrates
were apparent in AA affected wild-type mice, AA-developing IL-2þ / littermates had a reduced leukocyte inﬁltration,
and AA-resistant IL-2þ / mice had no inﬂammation. Lymph node cell analysis revealed a reduction in leukocyte
activation markers in AA-developing IL-2þ / mice. IL-2þ / mice presented with low level expression of cytokines
(IL-4, IL-10, interferon-c, transforming growth factor-b), upregulation of tumor necrosis factor receptors, and in-
creased leukocyte apoptosis susceptibility independent of AA expression. In the skin, CD4þ cells and monocytes
were reduced; activation markers were not upregulated and very few CD44v3þ or CD44v10þ leukocytes were
recovered. Taken together, our data suggest that AA resistance of IL-2þ /mice is because of the failure of activated
leukocyte recruitment, thus pointing toward an involvement of IL-2 in AA pathogenesis.
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Alopecia areata (AA) is a putative autoimmune disease of
anagen stage hair follicles (McElwee and Hoffmann, 2002;
Paus et al, 2003). In the C3H/HeJ mouse model, AA can be
transferred from spontaneous AA-affected mice to normal
haired littermates by full thickness skin grafts (McElwee
et al, 1998). Transfer experiments showed that CD4þ T
helper cells (TH) are essential for disease transfer, and AA
onset was restrained by regulatory T cells (McElwee et al,
2005). The cytokine profile of AA-affected mice reveals both
TH-1 and TH-2 are upregulated (McElwee et al, 2002). Be-
cause of the requirement for TH, the generalized upregu-
lation of cytokines, and the fact that the clinical AA
phenotype is restricted to hair follicles and other skin ap-
pendages (McElwee et al, 2001) we suspected that a
reduction in TH/TH factors would reduce the disease
incidence as a consequence of insufficient autoreactive T
cell activation.
We examined the role of interleukin (IL)-2 in AA using IL-
2þ / mice. IL-2 stimulates lymphocyte proliferation and
cytokine production (Paul, 1989), but also exerts regulatory
functions by promoting regulatory T cells (Malek, 2003) and
by increasing apoptosis susceptibility (Banz et al, 2002).
Homozygous IL-2 knockout mice are characterized by an-
emia, lymphoproliferative disorders and colitis (Horak, 1995;
Nelson, 2002; Schimpl et al, 2002). Because IL-2/ mice
have a high mortality rate in utero and have a significantly
curtailed life-span (Sadlack et al, 1993), our study was nec-
essarily limited to IL-2þ / mice. Heterozygous IL-2þ / mice
appear to have overtly normal hematopoiesis and immune
response regulation (Paul, 1989). Due to the monoallelic
expression of IL-2, however, they display reduced IL-2 lev-
els (Hollander et al, 1998) and are well suited to explore the
impact of IL-2 availability on immune response after full
thickness skin grafts from AA-affected mice. All animal ex-
periments were approved by the local animal care author-
ities (Giessen, Germany).
Heterozygous C3.129P2(B6)-Il2tm1Hor (IL-2þ / C3H/HeJ)
mice appeared overtly healthy with normal weight and un-
altered life expectation. Age- and sex-matched IL-2þ /þ or
IL-2þ / mice (6 months old) received full thickness skin
transplants of AA-affected C3H/HeJ mice (McElwee et al,
2003). Within 6–7 wk after skin grafting, 16 of 18 (88%) IL-
2þ /þ , but only 9/19 (47%) IL-2þ / mice (p 0.013) devel-
oped hair loss. Immunohistochemistry of skin revealed a
dense perifollicular and intrafollicular infiltrate of CD8þ cells
and a moderate perifollicular infiltrate of CD4þ cells in1Equal contributions.
Abbreviations: AA, alopecia areata; IFN, interferon; IL, interleukin;
LNC, lymph node cells; Mf, monocytes; R, receptor; SkIL, skin
infiltrating leukocytes; TGF, transforming growth factor; TH, T help-
er cells; TNF, tumor necrosis factor
Copyright r 2005 by The Society for Investigative Dermatology, Inc.
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Figure 1
Interleukin (IL)-2þ / mice are relative resistant to alopecia areata (AA) development. At 8 wk after induction of AA by grafting lesional AA-skin
from C3H/HeJ mice onto the back of the recipients (for details, see addendum), 88% of IL-2þ /þ mice (a), but only 47% of IL-2þ / mice (b)
developed AA. The ventral surface of four IL-2þ /þ mice with AA (a) and of 4 IL-2þ / mice, two of which developed AA (b) is shown. Immunohisto-
chemical staining (for details, see addendum) for CD4 (c–e) and CD8 (f–h) of frozen skin sections of IL-2þ /þ mice with AA (c,f), IL-2þ / mice with AA
(d,g) and IL-2þ / mice without AA (e, i, h) is shown. Moderate perifollicular infiltrates of CD4þ cells were identified in IL-2þ /þ mice (c) and IL-2þ /
mice with AA (d), dense peri- and intrafollicular infiltrates of CD8þ cells were seen in IL-2þ /þ mice with AA (f) and moderate CD8þ cell infiltrates
were apparent in IL-2þ / mice with AA (g). No perifollicular or intrafollicular infiltrates of CD4þ (e) or CD8þ (h) cells were observed in AA-resistant
IL-2þ / mice.
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IL-2þ /þ mice with AA development. AA-affected IL-2þ /
mice showed only moderate infiltrates of CD4þ and CD8þ
cells. AA-resistant IL-2þ / mice did not show CD4þ and
CD8þ cell infiltrates (Fig 1).
Serum levels of IL-2 were reduced and supernatants of
spleen cell (SC) and lymph node cell (LNC) cultures of IL-
2þ / C3H/HeJ mice contained less IL-2 than supernatants
of IL-2 competent mice (Table IA). The number of lymphoid
cells in spleen, draining lymph nodes and skin did not differ
significantly in non-manipulated IL-2þ /þ and IL-2þ / mice.
After skin transplantation, however, SC and skin infiltrating
leukocytes (SkIL) expanded less efficiently in IL-2þ / than
in IL-2þ /þ AA developing mice. Lymphocytes did not ex-
pand at all in AA-resistant IL-2þ / mice (Table IB). In spleen
and lymph nodes, the distribution between the major
lymphocyte subsets (CD4þ -, CD8þ -, B-, NK-cells, and
monocytes) did not differ significantly between IL-2þ / and
IL-2þ /þ mice. This was independent of whether the mice
did or did not develop AA (data not shown). The number of
CD4þ and of CD11bþ SkIL, however, was reduced in IL-
2þ / mice with AA as compared to IL-2þ /þ mice with AA
(Table IC). Also, activation markers were increased in LNC
and SkIL of IL-2þ /þ AA mice, but not in IL-2þ / AA mice.
There were two exceptions, CD152 was not increased in IL-
2þ /þ and IL-2þ / AA mice. Notably, too, CD25 expression
was not increased in SkIL of IL-2þ /þ AA mice and a similar
percentage of CD25þ cells was seen IL-2þ / AA mice. In
SkIL of AA-resistant IL-2þ / mice a further reduction in
CD25þ cells was noted. Upregulation of co-stimulatory
molecule expression was also much stronger in LNC and
SkIL of IL-2þ /þ than of IL-2þ / AA mice. Only CD80,
the preferential CD152 ligand (Sansom et al, 2003), was
expressed on a similar percentage of SkIL from IL-2þ / and
IL-2þ /þ AA mice. Activation marker and co-stimulatory
molecule expression did not significantly differ between IL-
2þ / AA mice and IL-2þ / mice not developing AA (Table
ID) further suggesting an impaired leukocyte activation in IL-
2þ / mice, although expression of the regulatory T cell
markers CD25 and CD152 was largely unaffected.
CD44s is involved in leukocyte activation and extrava-
sation (Rafi-Janajreh et al, 1998; Siegelman et al, 2000).
CD44v6 is primarily an activation marker (Marhaba et al,
2005). CD44v3 and CD44v10 are homing markers, partic-
ularly for SkIL (Ro¨sel et al, 1997; Seiter et al, 1999; Freysch-
midt-Paul et al, 2002). Expression of CD44s, CD44v3,
CD44v10 and CD44v6 was unaltered in LNC (data not
shown), but was reduced in SkIL of IL-2þ / mice. CD44
expression remained reduced in AA-affected IL-2þ / mice
and particularly the reduction in CD44v6 expression be-
came more striking in AA-affected IL-2þ / mice (Table IE),
where, in addition, LNC CD44v6 expression was reduced
(data not shown). The reduced recovery of CD44v6 likely
reflects a reduced responsiveness of the IL-2þ / lymph-
ocytes. In addition, reduced CD44 expression and, as a
consequence a weakness in leukocyte extravasation (Car-
low et al, 2001), obvioulsy hampers AA induction as appar-
ent by the low incidence of AA in IL-2þ / mice after the
transfer of AA-affected skin and the mild perifollicular infil-
trate in the few mice developing AA.
Expression of the cytokines IL-2, IL-4, IL-10, IL-12, in-
terferon (IFN)g, tumor necrosis factor (TNF)a, and trans-T
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forming growth factor (TGF)b was reduced in LNC and SkIL
of IL-2þ / as compared to IL-2þ /þ mice (data not shown).
Because IL-2 stimulates the production of TH-1 and TH-2
cytokines (Paul, 1989), it is not surprising that expression of
both regulatory and proinflammatory cytokines was re-
duced in AA-affected IL-2þ / as compared to IL-2þ /þAA
mice. The fact the IL-12, TNFa and TGFb, all three cytokines
being preferentially expressed by activated Mf, was further
reduced in draining LNC of AA-resistant IL-2þ / mice is
consistent with a general deficit in TH activation, i.e. the
reduced expression may reflect the reduced availability of
IL-2 and as a consequence a reduction in Mf activation
(Table IF).
CD95L and the death receptors CD120a and CD120b
were all upregulated in LNC and SkIL of IL-2þ / as com-
pared to IL-2þ /þ mice (data not shown) and remained el-
evated in IL-2þ / mice, which developed AA. Upregulation
of death receptor expression was accompanied by an in-
crease in apoptosis susceptibility as determined by Annex-
inV-FITC staining after overnight culture in the presence of
subthreshold levels of anti-CD3 (Table IG). It is generally
accepted that IL-2 is involved in the maintenance of lymph-
ocyte homeostasis by supporting activation induced cell
death via upregulation of death receptors, their ligands and
caspase 8 activation, or via passive apoptosis by the with-
drawal of IL-2 after cessation of antigen and IL-2 stimulation
(Lenardo, 1991; Kneitz et al, 1995; Refaeli et al, 1999).
Though the latter could be pronounced in IL-2þ / mice,
passive cell death has been shown to be mostly independ-
ent of death receptors and to proceed via downregulation of
anti-apoptotic proteins (Nelson, 2002; Schimpl et al, 2002).
Independent of these alternative death pathways, there is
obviously enough IL-2 available in IL-2þ / mice to enable
activation-induced cell death (AICD) as the levels of death
receptors and apoptosis susceptibility were increased in
AA-affected IL-2þ / mice. Accordingly, undue prevention of
AICD by a relative shortage in IL-2 may not be of major
importance for AA induction. Considering death receptor
expression in AA-resistant IL-2þ / mice, these were mostly
reduced as compared to AA-affected IL-2þ / mice, which
we interpret as a secondary phenomenon in the sense,
that T cell activation has not taken place. However, even
in AA-resistant IL-2þ / mice apoptosis susceptibility re-
mained elevated. Therefore, we suggest that quiescent
T cell survival may be reduced in IL-2þ / mice (Lenardo,
1991). Whether such an overshooting death of naı¨ve/resting
T cells indirectly contributes towards AA resistance remains
to be explored.
Taken together, a relative deficit in IL-2 did not promote
AA, but rather it hampered AA development. The incidence
of AA development after the transfer of AA-affected skin
was significantly reduced and even those IL-2þ / mice that
did develop AA displayed mild features of AA as compared
to IL-2þ /þ mice. What does this tell us about AA induction?
Taking the main features of IL-2, activation of TH, support-
ing AICD and maintaining the balance in regulatory T cells,
our data suggest that the activation of TH is the most im-
portant event for AA induction. The expansion of CD4þ T
cells was reduced, upregulation of activation markers was
impaired, Mf activation, expression of costimulatory mol-
ecules and cytokine secretion by activated Mf was ham-
pered and leukocyte migration (reduced CD44 expression)
was affected.
IL-2 is also important for maintaining the balance in reg-
ulatory T cells, and a reduction in IL-2 could be a prominent
feature of AA induction. In this case we would have ex-
pected an overshooting lymphoproliferation and an overall
increase in the incidence and severity of AA in IL-2þ / mice.
This was not the case. The third possibility whereby a rel-
ative shortage in IL-2 could affect AA induction relies on its
involvement in lymphocyte homeostasis. IL-2 supports
AICD, but IL-2 is also involved in the prevention of down-
regulation of anti-apoptotic proteins and can support rest-
ing T cell survival. These opposing features in the regulation
of Tcell survival, depending on their activation state, make it
difficult to evaluate the impact on T cell survival in view of
the relative AA resistance of IL-2þ / mice. Because AICD
was not impaired, however, i.e., death receptors were up-
regulated and Tcells, including Tcells of AA-resistant IL-2þ /
mice, were adequately driven into apoptosis it is obvious
that a disbalance in AICD is not of major importance during
the period of AA induction. Thus, without exception, the
features of reduced TH responsiveness remained or were
strengthened in IL-2þ / as compared to IL-2þ /þ AA mice.
We interpret these features that during AA induction regu-
latory functions of IL-2 are probably less important than its
role in TH activation.
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